3D printed personalised medications at the point of care

Synopsis

The manufacturing of 3D printed personalised medicines at the point of care (PoC) is expected to revolutionise the pharmaceutical sector. Here we present a range of 3D printing technologies that offer significant benefits in comparison to conventional manufacturing processes including rapid print times, automation, print accuracy, excellent palatability and medication adherence. The clinical evaluation of 3D printed medicines has shown that PoC manufacturing can improve patient treatment and wellbeing. In addition, 3D printing offers continuous manufacturing of medicines at affordable cost for a children and elderly patients. The presentation includes some regulatory aspects that should be considered for the design of printable medicines.